Company Overview:
national healthcare corporation - NHC
NHC Key Data
| Open $155.65 | Day Range 154.91 - 163.22 |
| 52 Week Range 89.17 - 174.54 | Market Cap $2.53B |
| Shares Outstanding 15.54M | Public Float 11.48M |
| Beta 0.59 | Rev. Per Employee N/A |
| P/E Ratio 21.22 | EPS $7.76 |
| Yield 157.30% | Dividend $0.64 |
| EX-DIVIDEND DATE Mar 31, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 126.71K |
|
An error occurred while fetching the data.
An error occurred while fetching the data.
An error occurred while fetching the data.
Insider Actions for National Healthcare Corporation - NHC
| Date | Name | Shares | Transaction | Value |
|---|
|
Mar 11, 2026
| James Paul Abernathy Director |
43,302
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $55.75 per share |
2,414,086.50
|
|
Mar 11, 2026
| James Paul Abernathy Director |
4,360
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Dec 30, 2025
| Brian F. Kidd SVP, CFO |
24,140
| Bona fide gift |
0.00
|
|
Jun 6, 2025
| Richard A. LaRoche Director |
205,760
| Bona fide gift Non-derivative transaction at $104.69 per share |
21,541,014.40
|
|
May 21, 2025
| Brian F. Kidd SVP, CFO |
23,714
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $108.61 per share |
2,575,577.54
|
|
May 21, 2025
| Brian F. Kidd SVP, CFO |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|